Docenz Injektionsvätska, suspension, förfylld spruta

Pays: Suède

Langue: suédois

Source: Läkemedelsverket (Medical Products Agency)

Ingrédients actifs:

influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat; influensavirus B/Hong Kong/330/2001-liknande stam (B/Shangdong/7/79), spjälkat virus, inaktiverat; influesavirus A/Moscow/10/99(H3N2)-liknande stam (A/Panama/2007/99 (RESVIR-17)), ytantigen, inaktiverat

Disponible depuis:

Mimer Medical

Code ATC:

J07BB02

DCI (Dénomination commune internationale):

influenza virus (A/New Caledonia/20/99 (H1N1)-like strain (A/New Caledonia/20/99 (IVR-116)), surface antigen, inactivated; influenza virus B/Hong-Kong -/330/2001- like strain (B/Shangdong/7/79), spjälkat virus, inactivated; influesavirus A/Moscow/10/99(H3N2)-like strain (A/Panama/2007/99 (RESVIR-17)), surface antigen, inactivated

forme pharmaceutique:

Injektionsvätska, suspension, förfylld spruta

Composition:

influensavirus B/Hong Kong/330/2001-liknande stam (B/Shangdong/7/79), spjälkat virus, inaktiverat 15 mikrog Aktiv substans; influesavirus A/Moscow/10/99(H3N2)-liknande stam (A/Panama/2007/99 (RESVIR-17)), ytantigen, inaktiverat 15 mikrog Aktiv substans; influensavirus A/New Caledonia/20/99 (H1N1)-liknande stam (A/New Caledonia/20/99 (IVR-116)), ytantigen, inaktiverat 15 mikrog Aktiv substans

Type d'ordonnance:

Receptbelagt

Domaine thérapeutique:

spjälkat virus eller ytantigen

Statut de autorisation:

Avregistrerad

Date de l'autorisation:

2004-10-29